healthcare-expenditure
Top StoriesBristol Myers, Pfizer, AbbVie Drugs Likely to Face U.S. Price Negotiation
Research ReportsClinical Trials Market Are Set to Witness Growth at a Cagr of 4.41% and Be Valued at Around Us$ 177.7 Billion by 2033
Research ReportsGeneral Anesthesia Drugs Market Is Expected to Reach a Valuation of Us$ 6.7 Billion by 2032
Top StoriesEU Must Do More to Tackle Antibiotic Shortages, Say Patient Groups
Sanofi Sees Decision on Zantac Dispute With Boehringer in Q1 at Earliest
Date: January 4, 2023
By Natalie Grover and Silvia Aloisi PARIS (Reuters) -French drugmaker Sanofi said on Wednesday its dispute with Germany’s Boehringer Ingelheim over potential liability for cancer claims in the United States, linked to heartburn drug Zantac, would be decided this quarter at the earliest. The two companies are in arbitration to decide what Sanofi’s obligations might...
‘The Icu Is Full’: Medical Staff on Frontline of China’s Covid Fight Say Hospitals Are ‘overwhelmed’
Date: December 26, 2022
By Martin Quin Pollard BEIJING (Reuters) – In more than three decades of emergency medicine, Beijing-based doctor Howard Bernstein said, he has never seen anything like this. Patients are arriving at his hospital in ever-increasing numbers; almost all are elderly and many are very unwell with COVID and pneumonia symptoms, he said. Bernstein’s account reflects...
Energy Crisis Risks Upending Europe’s Key Medicine Supply Chains – Industry Says
Date: October 27, 2022
By Natalie Grover LONDON (Reuters) – Surging energy costs in Europe risk accelerating an exodus of companies critical in the manufacture of essential medicines, further endangering drug supply chains hit by shortages at the height of COVID-19, drug ingredient makers say. Essential medicines are crucial in treating long-term conditions as well as for surgical procedures....
Roche Sales Decline More Than Expected as Covid Products Slide
Date: October 18, 2022
By Ludwig Burger (Reuters) -Roche’s quarterly sales declined 6% as a slump in COVID-19 treatments and diagnostic testing outweighed gains from haemophilia treatment Hemlibra and multiple sclerosis drug Ocrevus. Third-quarter revenue slipped to 14.74 billion Swiss francs ($14.84 billion), below market expectations of about 15.5 billion francs. “The third quarter of 2022 was particularly challenging...
Shaken by Heatwaves, U.S. Clinics Get Tips on Staying Cool
Date: October 5, 2022
By David Sherfinski NAGS HEAD, North Carolina (Thomson Reuters Foundation) – The day a patient collapsed out in the parking lot, nurse practitioner Alexis Hodges realized she needed a plan to deal with the extreme heat that has overwhelmed U.S. community health clinics from the East Coast to California this summer. Hodges, who works in...
France’s 8th Wave of Covid Is Gaining in Intensity – Health Official
Date: October 4, 2022
PARIS (Reuters) – France has entered an eighth wave of the COVID-19 virus, as the winter season approaches, said a leading French health official. “Yes, we are in this eighth wave,” said Brigitte Autran, who is a member of the government’s vaccination strategic board. “All the indicators are on the up,” added Autran. France’s COVID...